Author

C. Mancusi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

C. A. Mendoza· 1 shared C. D. Steele· 1 shared G. Zoumpoulidou· 1 shared J. Manji· 1 shared M. Denman· 1 shared N. Pillay· 1 shared R. M. Ahmed· 1 shared S. J. Strauss· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. A. Mendoza

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Therapeutic vulnerability to PARP1/2 inhibition in RB1-mutant osteosarcoma

G. Zoumpoulidou, C. A. Mendoza, C. Mancusi, R. M. Ahmed, M. Denman, C. D. Steele, J. Manji, N. Pillay, S. J. Strauss, S. Mittnacht

This study shows RB1-mutant osteosarcoma is hypersensitive to PARP1/2 inhibitors, with sensitivity linked to replication checkpoint activation rather than homologous repair defects.

bioRxiv · Dec 28, 2020 · PreprintCancer Biology